162 related articles for article (PubMed ID: 30641744)
21. Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention.
Roth CL; Elfers C; Lass N; Reinehr T
Pediatr Diabetes; 2017 Sep; 18(6):485-491. PubMed ID: 27402552
[TBL] [Abstract][Full Text] [Related]
22. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes.
Yamada H; Saito T; Aoki A; Asano T; Yoshida M; Ikoma A; Kusaka I; Toyoshima H; Kakei M; Ishikawa SE
Endocr J; 2015; 62(5):417-21. PubMed ID: 25753914
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
[TBL] [Abstract][Full Text] [Related]
24. Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescents.
Tuhan H; Abacı A; Anık A; Çatlı G; Küme T; Çalan ÖG; Acar S; Böber E
Diabetes Res Clin Pract; 2016 Apr; 114():37-42. PubMed ID: 27103367
[TBL] [Abstract][Full Text] [Related]
25. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
[TBL] [Abstract][Full Text] [Related]
26. Association of serum angiopoietin-like protein 2 with elevated risk of cardiovascular diseases in subjects with type 2 diabetes.
El-Lebedy D
J Diabetes Complications; 2019 Nov; 33(11):107421. PubMed ID: 31484627
[TBL] [Abstract][Full Text] [Related]
27. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity.
Fu Z; Berhane F; Fite A; Seyoum B; Abou-Samra AB; Zhang R
Sci Rep; 2014 May; 4():5013. PubMed ID: 24852694
[TBL] [Abstract][Full Text] [Related]
28. Betatrophin for diagnosis and prognosis of mothers with gestational diabetes mellitus.
Pan R; Zhang H; Yu S; Deng J; Ma S; Li Y; Yuan G; Wang J
J Int Med Res; 2019 Feb; 47(2):710-717. PubMed ID: 30392425
[TBL] [Abstract][Full Text] [Related]
29. The Correlation Between Circulating Betatrophin and Insulin Resistance in General Population: A Meta-Analysis.
Xu J; Lin Y; Zhou H; Zhao L; Xiang G
Horm Metab Res; 2017 Oct; 49(10):760-771. PubMed ID: 28931172
[TBL] [Abstract][Full Text] [Related]
30. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
31. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
32. Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.
Liu D; Li S; He H; Yu C; Li X; Liang L; Chen Y; Li J; Li J; Sun X; Tian H; An Z
Oncotarget; 2017 Mar; 8(11):17510-17517. PubMed ID: 28177922
[TBL] [Abstract][Full Text] [Related]
33. [Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors].
Song S; Wang J; Guo C; Jiang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):969-74. PubMed ID: 27640796
[TBL] [Abstract][Full Text] [Related]
34. Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China.
Zheng T; Ge B; Liu H; Chen B; Qin L; Xiao L; Song J
Cardiovasc Diabetol; 2018 Jul; 17(1):84. PubMed ID: 30007407
[TBL] [Abstract][Full Text] [Related]
35. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes.
Espes D; Lau J; Carlsson PO
Diabetologia; 2014 Jan; 57(1):50-3. PubMed ID: 24078058
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery.
Ejarque M; Borlaug M; Vilarrasa N; Martinez-Perez B; Llauradó G; Megía A; Helland T; Gutierrez C; Serena C; Folkestad O; Nuñez-Roa C; Roche K; Casajoana A; Fradera R; González-Clemente JM; López M; Mohn AC; Nedrebø BG; Nogueiras R; Mellgren G; Fernø J; Fernández-Veledo S; Vendrell J
Transl Res; 2017 Jun; 184():35-44.e4. PubMed ID: 28347650
[TBL] [Abstract][Full Text] [Related]
37. Role of Betatrophin and Inflammation Markers in Type 2 Diabetes Mellitus, Prediabetes and Metabolic Syndrome.
Onalan E; Bozkurt A; Gursu MF; Yakar B; Donder E
J Coll Physicians Surg Pak; 2022 Mar; 32(3):303-307. PubMed ID: 35148580
[TBL] [Abstract][Full Text] [Related]
38. High betatrophin in coronary patients protects from cardiovascular events.
Leiherer A; Ebner J; Muendlein A; Brandtner EM; Zach C; Geiger K; Fraunberger P; Drexel H
Atherosclerosis; 2020 Jan; 293():62-68. PubMed ID: 31862484
[TBL] [Abstract][Full Text] [Related]
39. Circulating Angiopoietin-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis.
Varikasuvu SR; Panga JR; Satyanarayana MV
Gynecol Endocrinol; 2019 Mar; 35(3):190-197. PubMed ID: 30614305
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study.
Wang H; Lai Y; Han C; Liu A; Fan C; Wang H; Zhang H; Ding S; Teng W; Shan Z
Sci Rep; 2016 Jun; 6():28431. PubMed ID: 27345212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
